Postoperative adjuvant chemotherapy significantly improves survival for osteosarcoma patients. This treatment, including high-dose methotrexate and Adriamycin, offers better outcomes compared to no chemotherapy, establishing its crucial role in treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: